FDA Approves New Orphan Drug for Chronic Myelogenous Leukemia

News   Sep 11, 2012

 
FDA Approves New Orphan Drug for Chronic Myelogenous Leukemia
 
 
 

RELATED ARTICLES

Genomics Researchers Showcase their Applications of Droplet Digital PCR at ASHG 2017 Annual Meeting

News

The sensitivity and reliability of Droplet Digital PCR will be showcased in over a dozen presentations at the American Society of Human Genetics (ASHG) 2017 Annual Meeting.

READ MORE

Model Predicts How E. coli Bacteria Adapt Under Stress

News

Scientists have developed a genome-scale model that can accurately predict how E. coli bacteria respond to temperature changes and genetic mutations, providing systems-level understanding of how cells adapt under environmental stress.

READ MORE

Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE